. SPR sensogram of glycopeptide 4 binding to GalNAc-T4. Sensogram (left) and fitting (right) of SPR data for binding of glycopeptide 4 to GalNAc-T4. Glycopeptide concentrations are reported in the inset legend of the sensogram (left). The end-point values for each injection were plotted against glycopeptide concentration (right). Note that the Kd could not be determined for peptide 4 because binding saturation could not be achieved. However, the Kd was accurately determined for glycopeptide 6 as 70 ± 15 µΜ (see Figure 1b) . 
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(-T*T-) Figure S4. (a) STD-NMR-derived epitope mapping obtained for (-T*T-) with GalNAc-T4.
Protons that could not be accurately analyzed in the STD spectrum were not mapped. In particular, the signal of the anomeric proton H1 of GalNAc could not be analyzed in the STD spectra due to their close distance to the HDO resonance, H6 protons could not be analysed in the STD spectra due to Tris buffer interference and the Hα of Gly amino acids protons due to their overlap with the sugar protons. The proton resonances that overlap in the spectrum are identified in the figure and displayed with *. Protons that could not be accurately analyzed in the STD spectrum were not mapped. In particular, the signal of the anomeric proton H1 of GalNAc could not be analyzed in the STD spectra due to their close distance to the HDO resonance, H6 protons could not be analysed in the STD spectra due to Tris buffer interference and the Hα of Gly amino acids protons due to their overlap G2   G4   G8   G10   G12   G15   A1   A3   A16   A13   T5   T14   T6   P7  P9   A11   * 1   Proton  % STD  relative   H2 -GalNAc-T5  &GalNAc-T14  100   H3 -GalNAcT5  &GalNAc-T14  70   H4 -GalNAc-T5  &GalNAc-T14  38   H5 -GalNAc-T5&  GalNAc-T14  43 NHAc -GalNAc-T5 85
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Figure S6. (a) STD-NMR-derived epitope mapping obtained for 6 (-T*--T*T-) with GalNAc-T4.
Protons that could not be accurately analyzed in the STD spectrum were not mapped. In particular, the signal of the anomeric proton H1 of GalNAc could not be analyzed in the STD spectra due to their close distance to the HDO resonance, H6 protons could not be analysed in the STD spectra due to Tris buffer interference and the Hα of Gly amino acids protons due to their overlap with the sugar protons. The proton resonances that overlap in the spectrum are identified in the figure and display with *. (b) Relative STD percentages for proton resonances relative to the NHAc methyl. Table S3 . Figure S8 . Determination of UDP-3 H-GalNAc hydrolysis. Top Panels: Representative Sephadex G10 chromatograms showing extent of UDP-GalNAc hydrolysis. Columns represent each (glyco)peptide substrate while rows represent GalNAc-T4 transferase construct. Transferase reaction products (after Dowex-1X8) were applied to Sephadex G10 chromatography and the eluted fractions counted for 3 H-activity. Note the first eluting peak represents transfer to (glyco)peptide while the second eluting peak represents transfer to water (i.e. free 3 H-GalNAc). Bottom Panel: Summary of UDP-3 H-GalNAc hydrolysis. Average hydrolysis for each substrate and transferase combination obtained from 2 to 5 individual Sephadex G10 determinations. 
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Lectin Mutant
Lectin/ Catalytic Mutant Figure S12. Conformational changes of the LFL. The crystal structure of GalNAc-T4 in complex with the peptide 3 was superimposed with the crystal structure of GalNAc-T4 in complex with the peptide 6. Note that the crystals for both crystal structures have two molecules in the asymmetric unit. For this superposition analysis, we used the two monomers of GalNAc-T4 that were soaked with peptide 3 (LFL in green and blue) whereas we have only used the monomer of GalNAc-T4 in complex with UDP and peptide 6 (LFL in black). Note that for one of the monomers of the GalNAc-T4-peptide 3 complex asymmetric unit is there only electron density visualized for the GalNAc moiety, for the other monomer we visualized Thr3 and its covalently bound GalNAc residue of peptide 3. The GalNAc moieties of peptide 3 were shown as green (free GalNAc) and black (sugar bound to Thr3) carbon atoms. The GalNAc moieties for peptide 6 were shown as orange carbon atoms. The amino acids of peptide 3 (only Thr3 is visualized) and 6 were shown as black and green carbon atoms, respectively. The residues that are listed in the figure correspond to the LFL of the structure of GalNAc-T4-UDP-peptide 6. Note that only the residues eliminated and replaced by GGG to generate the LFL mutant are labelled. 
